Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

Subsequent Events
9 Months Ended
Sep. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events
Subsequent Events

Reverse Stock Split

As discussed in Note 1, we effected a 30-for-1 reverse stock split of our common stock on October 24, 2019.

Settlement of Excess Consideration Note

On October 24, 2019, the Excess Consideration Note matured and was settled for $6,024,489. Buyer withheld from the settlement certain amounts as security for future claims and uncollected receivables. See Note 1 for additional details.

Settlement of Advance from NovellusDx, Ltd.

In October 2019, we settled our Advance from NDX by paying $1,100,000 and agreeing to pay nine monthly payments of $50,000 commencing in November 2019.

Loan from Atlas Sciences, LLC
On October 21, 2019, we issued a $1,347,500 unsecured promissory note to Atlas Sciences, as described further in Note 1. We utilized the proceeds from this note to partially repay our Convertible Note.